GERPAC 2024 is coming soon!

MB Therapeutics will be present at GERPAC 2024 to share its latest innovations with healthcare professionals regarding the personalization of medications through pharmaceutical 3D printing.

Meet the MB Therapeutics Team at GERPAC

Our start-up will be represented by our CEO, Stéphane Roulon and our doctoral engineer, Léna Lemierre. Their presence underscores our commitment to innovation and research in addressing the needs of healthcare professionals.

Stéphane and Léna will be available to engage in discussions, present our latest advancements, and share MB Therapeutics’ innovative projects. Don’t miss this opportunity to meet them!

What is GERPAC?

GERPAC -European Society Of Hospital Pharmaceutical technologies- is an annual congress that brings together hospital pharmacy professionals, pharmaceutical industry experts, and researchers. This event is a major platform for the exchange of knowledge and innovations in the preparation and handling of medications in a hospital environment.

On the agenda:

•Expert talks discussing advancements in pharmaceutical technology, with a particular focus on hospital pharmaceutical technologies and biotherapies.

•Interactive case studies offering the opportunity to solve three current issues presented by participants in real-time.

•Oral communications and posters selected by the scientific committee.

MB Therapeutics’ presence at this event reflects our determination to actively contribute to the evolution of the pharmaceutical sector and to establish strategic partnerships for the future.

Meet at Hyères!

As a bonus, a new slogan: